Immune check could stop virus after lung transplants
NCT ID NCT06494033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether monitoring the immune response to the cytomegalovirus (CMV) can help prevent CMV disease in people who receive a lung transplant. About 100 adult lung transplant patients who have had CMV in the past will be followed. The goal is to see if tracking CMV immunity can guide treatment and improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cutting radiation in CT scans: a new test of Ultra-Low-Dose imaging
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- Breathe easier: study tests if renovating homes and purifying indoor air can transform lung health
- Could a simple breath test spot hidden diseases early?
- Scientists examine lung cells to understand chronic lung disease
- New bedside test may cut blood transfusions in lung transplants